Molina Healthcare, Inc. (MOH)

$296.07

+1.43

(+0.49%)▲

Market is closed - opens 8 PM, 22 Nov 2024

Performance

  • $288.64
    $298.89
    $296.07
    downward going graph

    2.51%

    Downside

    Day's Volatility :3.43%

    Upside

    0.94%

    downward going graph
  • $272.69
    $423.92
    $296.07
    downward going graph

    7.9%

    Downside

    52 Weeks Volatility :35.67%

    Upside

    30.16%

    downward going graph

Returns

PeriodMolina Healthcare, Inc.Sector (Health Care)S&P500
3 Months
-15.14%
-7.6%
5.3%
6 Months
-13.93%
-2.3%
11.2%
1 Year
-18.19%
10.1%
30.4%
3 Years
-2.72%
7.5%
26.0%

Highlights

Market Capitalization
16.2B
Book Value
$83.68
Earnings Per Share (EPS)
19.01
PE Ratio
14.86
PEG Ratio
-0.62
Wall Street Target Price
369.204
Profit Margin
3.05%
Operating Margin TTM
4.75%
Return On Assets TTM
6.9%
Return On Equity TTM
26.45%
Revenue TTM
37.5B
Revenue Per Share TTM
649.83
Quarterly Revenue Growth YOY
17.4%
Gross Profit TTM
3.9B
EBITDA
1.8B
Diluted Eps TTM
19.01
Quarterly Earnings Growth YOY
0.34
EPS Estimate Current Year
23.48
EPS Estimate Next Year
26.17
EPS Estimate Current Quarter
5.94
EPS Estimate Next Quarter
5.98

Analyst Recommendation

Hold
    42%Buy
    52%Hold
    4%Sell
Based on 21 Wall street analysts offering stock ratings for Molina Healthcare, Inc.(by analysts ranked 0 to 5 stars)
Based on 21 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
9
9
9
Hold
11
11
9
Sell
1
1
1

Analyst Forecast

What analysts predicted

Upside of 24.7%

Current $296.07
Target $369.20

Company Financials

FY18Y/Y Change
Revenue
18.9B
↓ 4.99%
Net Income
707.0M
↓ 238.09%
Net Profit Margin
3.74%
↑ 6.32%
FY19Y/Y Change
Revenue
16.8B
↓ 10.91%
Net Income
737.0M
↑ 4.24%
Net Profit Margin
4.38%
↑ 0.64%
FY20Y/Y Change
Revenue
19.4B
↑ 15.41%
Net Income
673.0M
↓ 8.68%
Net Profit Margin
3.46%
↓ 0.92%
FY21Y/Y Change
Revenue
27.8B
↑ 42.98%
Net Income
659.0M
↓ 2.08%
Net Profit Margin
2.37%
↓ 1.09%
FY22Y/Y Change
Revenue
32.0B
↑ 15.13%
Net Income
792.0M
↑ 20.18%
Net Profit Margin
2.48%
↑ 0.11%
FY23Y/Y Change
Revenue
34.1B
↑ 6.56%
Net Income
1.1B
↑ 37.75%
Net Profit Margin
3.2%
↑ 0.72%
Q2 FY23Q/Q Change
Revenue
8.3B
↑ 2.18%
Net Income
309.0M
↓ 3.74%
Net Profit Margin
3.71%
↓ 0.23%
Q3 FY23Q/Q Change
Revenue
8.5B
↑ 2.65%
Net Income
245.0M
↓ 20.71%
Net Profit Margin
2.87%
↓ 0.84%
Q4 FY23Q/Q Change
Revenue
9.0B
↑ 5.85%
Net Income
216.0M
↓ 11.84%
Net Profit Margin
2.39%
↓ 0.48%
Q1 FY24Q/Q Change
Revenue
9.9B
↑ 9.76%
Net Income
301.0M
↑ 39.35%
Net Profit Margin
3.03%
↑ 0.64%
Q2 FY24Q/Q Change
Revenue
9.9B
↓ 0.73%
Net Income
301.0M
↑ 0.0%
Net Profit Margin
3.05%
↑ 0.02%
Q3 FY24Q/Q Change
Revenue
10.3B
↑ 4.88%
Net Income
326.0M
↑ 8.31%
Net Profit Margin
3.15%
↑ 0.1%
FY18Y/Y Change
Total Assets
7.2B
↓ 15.55%
Total Liabilities
5.5B
↓ 22.81%
FY19Y/Y Change
Total Assets
6.8B
↓ 5.13%
Total Liabilities
4.8B
↓ 12.35%
FY20Y/Y Change
Total Assets
9.5B
↑ 40.44%
Total Liabilities
7.4B
↑ 54.05%
FY21Y/Y Change
Total Assets
12.2B
↑ 28.08%
Total Liabilities
9.6B
↑ 28.82%
FY22Y/Y Change
Total Assets
12.3B
↑ 0.86%
Total Liabilities
9.4B
↓ 2.39%
FY23Y/Y Change
Total Assets
14.9B
↑ 20.94%
Total Liabilities
10.7B
↑ 14.19%
Q2 FY23Q/Q Change
Total Assets
13.7B
↑ 2.17%
Total Liabilities
10.0B
↓ 0.43%
Q3 FY23Q/Q Change
Total Assets
14.9B
↑ 8.85%
Total Liabilities
11.0B
↑ 9.47%
Q4 FY23Q/Q Change
Total Assets
14.9B
↑ 0.15%
Total Liabilities
10.7B
↓ 2.86%
Q1 FY24Q/Q Change
Total Assets
15.5B
↑ 4.17%
Total Liabilities
11.0B
↑ 3.21%
Q2 FY24Q/Q Change
Total Assets
15.2B
↓ 2.11%
Total Liabilities
10.3B
↓ 6.15%
Q3 FY24Q/Q Change
Total Assets
15.8B
↑ 3.77%
Total Liabilities
11.0B
↑ 6.25%
FY18Y/Y Change
Operating Cash Flow
-314.0M
↓ 139.05%
Investing Cash Flow
1.1B
↓ 206.52%
Financing Cash Flow
-1.2B
↓ 287.58%
FY19Y/Y Change
Operating Cash Flow
427.0M
↓ 235.99%
Investing Cash Flow
-293.0M
↓ 125.63%
Financing Cash Flow
-552.0M
↓ 53.73%
FY20Y/Y Change
Operating Cash Flow
1.9B
↑ 342.62%
Investing Cash Flow
-400.0M
↑ 36.52%
Financing Cash Flow
225.0M
↓ 140.76%
FY21Y/Y Change
Operating Cash Flow
2.1B
↑ 12.12%
Investing Cash Flow
-1.7B
↑ 313.25%
Financing Cash Flow
-183.0M
↓ 181.33%
FY22Y/Y Change
Operating Cash Flow
773.0M
↓ 63.52%
Investing Cash Flow
-790.0M
↓ 52.21%
Financing Cash Flow
-441.0M
↑ 140.98%
Q2 FY23Q/Q Change
Operating Cash Flow
487.0M
↓ 46.83%
Investing Cash Flow
-137.0M
↓ 54.64%
Financing Cash Flow
10.0M
↓ 115.38%
Q3 FY23Q/Q Change
Operating Cash Flow
949.0M
↑ 94.87%
Investing Cash Flow
-719.0M
↑ 424.82%
Financing Cash Flow
-6.0M
↓ 160.0%

Technicals Summary

Sell

Neutral

Buy

Molina Healthcare, Inc. is currently in a neutral trading position according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Molina Healthcare, Inc.
Molina Healthcare, Inc.
2.81%
-13.93%
-18.19%
-2.72%
117.13%
The Cigna Corp
The Cigna Corp
0.99%
-3.86%
12.88%
52.87%
60.72%
Unitedhealth Group Incorporated
Unitedhealth Group Incorporated
5.08%
14.7%
11.29%
37.24%
117.14%
Cvs Health Corporation
Cvs Health Corporation
-2.3%
-0.85%
-16.52%
-38.89%
-24.17%
Humana Inc.
Humana Inc.
12.82%
-17.34%
-42.03%
-32.01%
-13.15%
Elevance Health, Inc
Elevance Health, Inc
-5.87%
-27.15%
-15.54%
-5.23%
35.32%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Molina Healthcare, Inc.
Molina Healthcare, Inc.
14.97
14.86
-0.62
23.48
0.26
0.07
NA
83.68
The Cigna Corp
The Cigna Corp
30.56
30.57
0.77
28.5
0.08
0.03
0.02
150.61
Unitedhealth Group Incorporated
Unitedhealth Group Incorporated
38.29
38.29
1.61
27.61
0.15
0.07
0.01
102.42
Cvs Health Corporation
Cvs Health Corporation
13.51
14.15
1.92
5.62
0.07
0.02
0.05
59.57
Humana Inc.
Humana Inc.
24.22
24.22
1.27
16.14
0.08
0.04
0.01
145.88
Elevance Health, Inc
Elevance Health, Inc
14.58
14.35
0.73
33.02
0.16
0.06
0.02
188.74
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Molina Healthcare, Inc.
Molina Healthcare, Inc.
Hold
$16.8B
117.13%
14.97
3.05%
The Cigna Corp
The Cigna Corp
Buy
$89.7B
60.72%
30.56
1.32%
Unitedhealth Group Incorporated
Unitedhealth Group Incorporated
Buy
$545.0B
117.14%
38.29
3.64%
Cvs Health Corporation
Cvs Health Corporation
Buy
$70.5B
-24.17%
13.51
1.37%
Humana Inc.
Humana Inc.
Buy
$33.4B
-13.15%
24.22
1.18%
Elevance Health, Inc
Elevance Health, Inc
Buy
$92.9B
35.32%
14.58
3.69%

Insights on Molina Healthcare, Inc.

  • Increasing Revenue

    Revenue is up for the last 2 quarters, 9.85B → 10.34B (in $), with an average increase of 4.7% per quarter

  • Increasing Net Profit

    Netprofit is up for the last 4 quarters, 216.0M → 326.0M (in $), with an average increase of 12.0% per quarter

  • Vs CI

    In the last 1 year, The Cigna Corp has given 12.9% return, outperforming this stock by 31.1%

  • Vs CI

    In the last 3 years, The Cigna Corp has given 53.6% return, outperforming this stock by 54.7%

Institutional Holdings

  • Vanguard Group Inc

    11.65%

  • BlackRock Inc

    9.07%

  • Capital World Investors

    8.97%

  • T. Rowe Price Associates, Inc.

    7.02%

  • Capital Research Global Investors

    6.10%

  • Wellington Management Company LLP

    4.83%

Company Information

molina healthcare is a fortune 500 company that is focused exclusively on government-sponsored health care programs for families and individuals who qualify for government sponsored health care. molina healthcare contracts with state governments and serves as a health plan providing a wide range of quality health care services to families and individuals. molina healthcare offers health plans in california, florida, illinois, michigan, new mexico, ohio, south carolina, texas, utah, washington, wisconsin and puerto rico. molina also offers a medicare product and has been selected in several states to participate in duals demonstration projects to manage the care for those eligible for both medicaid and medicare. molina healthcare owns and operates primary care clinics in california, florida, new mexico, washington and virginia. our medical offices provide individuals who qualify for government sponsored programs with medical care including prenatal care, immunizations, and flu shots

Organization
Molina Healthcare, Inc.
Employees
18000
CEO
Mr. Joseph Michael Zubretsky
Industry
Health Services

FAQs